月湖免疫治疗
MLTX
9.55
-0.71
-6.92%
月湖免疫治疗
US · MLTX
#3305 按市值排名
上市于 2020
9.55
-0.71
-6.92%
实时 - 追踪5344个代码 - 心跳于510秒前
· 2026-10-16 19:42
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了2家。
- 机构持股总比例下降了1.5个百分点。
机构持股
- 机构持股比例
- 87.43% -1.51pp
- 机构数量
- 205 +2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Hedge Fund48.97%
Mutual Fund18.27%
VC/PE Fund13.09%
Individual/Insider7.80%
Private Company3.95%
Public Company2.96%
Government Pension Fund0.11%
Other4.77%
主要股东 截至 2026-06-30
BVF Partners L.P.
18.80% · 16.00M 股
Deep Track Capital, LP
8.22% · 7.00M 股
T. Rowe Price Group, Inc.
6.25% · 5.32M 股
D. E. Shaw & Co., L.P.
3.95% · 3.37M 股
Cormorant Asset Management, LP
3.77% · 3.21M 股
Janus Henderson Group plc
3.63% · 3.09M 股
Jorge da Silva
3.26% · 2.77M 股
Kristian Reich
3.23% · 2.75M 股
Logos Global Management, L.P.
3.14% · 2.68M 股
Weiss Asset Management, LLC
3.03% · 2.58M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 23次买入 · 27次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| BVF Partners L.P. | -- | 18.80% |
| Jorge da Silva | Chief Executive Officer | 3.26% |
| Kristian Reich | Co-Founder & CSO | 3.23% |
| Matthias Bodenstedt | Chief Financial Officer | 1.31% |
| Simon Sturge | Independent Chairperson | -- |
| Catherine Moukheibir | Independent Director | -- |
| Cormorant Asset Management, LP | -- | -- |
| Andrew Phillips | Independent Director | -- |
| Ramnik Xavier | Independent Director | -- |
| Spike Loy | Independent Director | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-26 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -1,100 | $20.00 |
| 2026-07-21 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -52,448 | $20.00–20.02 |
| 2026-07-19 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -43,700 | $20.09 |
| 2026-07-14 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -16,105 | $20.01 |
| 2026-07-09 | Jorge da Silva | Chief Executive Officer | Automatic Disposition | -102,225 | $20.01–20.02 |
| 2026-06-30 | Jorge da Silva | Chief Executive Officer | Automatic Disposition | -47,775 | $20.03 |
| 2026-06-29 | Jorge da Silva | Chief Executive Officer | Intent to Sell (Form 144) | -150,000 | $20.03 |
| 2026-06-21 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -39,120 | $22.04 |
| 2026-06-17 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -17,876 | $19.60–19.68 |
| 2026-06-16 | BVF Partners L.P. | -- | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Catherine Moukheibir | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Andrew Phillips | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Ramnik Xavier | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Spike Loy | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -150,000 | $18.70–19.43 |
| 2026-06-14 | Kristian Reich | Co-Founder & CSO | Intent to Sell (Form 144) | -150,000 | $19.00 |
| 2026-05-10 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -13,653 | $20.02 |
| 2026-04-13 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -2,426 | $19.56 |
| 2026-04-12 | Jorge da Silva | Chief Executive Officer | Open Market Disposition | -150,000 | $18.23–18.41 |
| 2026-04-09 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -87,795 | $18.94–19.51 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:42:56 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
月湖免疫治疗 讨论区 0 条评论